According to the company’s website news release on November 10, 2022, in light of recent developments, the Company announces that it has revised its consolidated earnings forecasts announced on May 12, 2022 at the meeting of the Board of Directors held on November 10, 2022.
Reasons for revision
Regarding the consolidated earnings forecasts for the fiscal year ending March 31, 2023, although sales of industrial film fell due to a temporary deterioration in the market, as sales of raw materials and reagents for PCR testing grew, etc., net sales remain unchanged from the previously announced figure (announced on May 12, 2022). On the other hand, operating profit, ordinary profit, and profit attributable to owners of parent are expected to be less than the previously announced figures, due to a delay in the improvement of profitability as product price revisions were unable to keep up with rising raw material and fuel prices, and due to a deterioration in the industrial film market.
(Note) The above business forecasts have been prepared based on the information available as of the date of this announcement, and actual results may differ from these forecasts due to various factors.
